ServiceNow (NOW) 10-Q 26 Apr 23 2023 Q1 Quarterly report Financial data

Cover

Cover shares in Millions	3 Months Ended
	Mar. 31, 2023 shares
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35580
Entity Registrant Name	SERVICENOW, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-2056195
Entity Address, Address Line One	2225 Lawson Lane
Entity Address, City or Town	Santa Clara
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95054
City Area Code	408
Local Phone Number	501-8550
Title of 12(b) Security	Common stock, par value $0.001 per share
Trading Symbol	NOW
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Shares of common stock, outstanding (in shares)	203.7
Entity Central Index Key	0001373715
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,852	$ 1,470
Short-term investments	3,062	2,810
Accounts receivable, net	1,109	1,725
Current portion of deferred commissions	392	369
Prepaid expenses and other current assets	319	280
Total current assets	6,734	6,654
Deferred commissions, less current portion	777	742
Long-term investments	2,239	2,117
Property and equipment, net	1,117	1,053
Operating lease right-of-use assets	682	682
Intangible assets, net	212	232
Goodwill	823	824
Deferred tax assets	640	636
Other assets	390	359
Total assets	13,614	13,299
Current liabilities:
Accounts payable	228	274
Accrued expenses and other current liabilities	694	975
Current portion of deferred revenue	4,742	4,660
Current portion of operating lease liabilities	97	96
Total current liabilities	5,761	6,005
Deferred revenue, less current portion	53	70
Operating lease liabilities, less current portion	655	650
Long-term debt, net	1,486	1,486
Other long-term liabilities	59	56
Total liabilities	8,014	8,267
Commitments and contingencies
Stockholders’ equity:
Common stock	0	0
Additional paid-in capital	5,182	4,796
Accumulated other comprehensive loss	(70)	(102)
Retained earnings	488	338
Total stockholders’ equity	5,600	5,032
Total liabilities and stockholders’ equity	$ 13,614	$ 13,299

Condensed Consolidated Statemen

Condensed Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Millions		3 Months Ended
		Mar. 31, 2023	Mar. 31, 2022
Revenues:
Total revenues		$ 2,096	$ 1,722
Cost of revenues:
Total cost of revenues	[1]	438	369
Gross profit		1,658	1,353
Operating expenses:
Sales and marketing	[1]	823	673
Research and development	[1]	492	414
General and administrative	[1]	199	179
Total operating expenses	[1]	1,514	1,266
Income from operations		144	87
Interest income		60	6
Other expense, net		(16)	(8)
Income before income taxes		188	85
Provision for income taxes		38	10
Net income		$ 150	$ 75
Net income per share - basic (in USD per share)		$ 0.74	$ 0.38
Net income per share - diluted (in USD per share)		$ 0.73	$ 0.37
Weighted-average shares used to compute net income per share - basic (in shares)		203,385	200,088
Weighted-average shares used to compute net income per share - diluted (in shares)		204,263	202,800
Other comprehensive income (loss):
Foreign currency translation adjustments		$ 13	$ (12)
Unrealized gain (loss) on investments, net of tax		19	(38)
Other comprehensive income (loss)		32	(50)
Comprehensive income		182	25
Subscription
Revenues:
Total revenues		2,024	1,631
Cost of revenues:
Total cost of revenues	[1]	354	275
Professional services and other
Revenues:
Total revenues		72	91
Cost of revenues:
Total cost of revenues	[1]	$ 84	$ 94
[1]Includes stock-based compensation as follows: Three Months Ended March 31, 2023 2022 Cost of revenues: Subscription $ 46 $ 36 Professional services and other $ 14 $ 16 Operating expenses: Sales and marketing $ 126 $ 105 Research and development $ 135 $ 115 General and administrative $ 60 $ 53

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cost of revenues | Subscription
Share-based compensation expense	$ 46	$ 36
Cost of revenues | Professional services and other
Share-based compensation expense	14	16
Sales and marketing
Share-based compensation expense	126	105
Research and development
Share-based compensation expense	135	115
General and administrative
Share-based compensation expense	$ 60	$ 53

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Millions	Total	Cumulative Effect, Period Of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period Of Adoption, Adjustment	Retained Earnings	Retained Earnings Cumulative Effect, Period Of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021			199,608
Beginning balance at Dec. 31, 2021	$ 3,695	$ (2)	$ 0	$ 3,665	$ (19)	$ (4)	$ 17	$ 34
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)	800		849
Common stock issued under employee stock plans	$ 105			105
Taxes paid related to net share settlement of equity awards	(150)			(150)
Stock-based compensation	324			324
Other comprehensive income, net of tax	(50)							(50)
Net income	75					75
Settlement of 2022 Notes conversion feature	(21)			(21)
Benefit from exercise of 2022 Note Hedge	21			21
Ending balance (in shares) at Mar. 31, 2022			200,457
Ending balance at Mar. 31, 2022	3,997		$ 0	3,925		88		(16)
Beginning balance (in shares) at Dec. 31, 2022			202,882
Beginning balance at Dec. 31, 2022	$ 5,032		$ 0	4,796		338		(102)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued under employee stock plans (in shares)	900		858
Common stock issued under employee stock plans	$ 117			117
Taxes paid related to net share settlement of equity awards	(112)			(112)
Stock-based compensation	381			381
Other comprehensive income, net of tax	32							32
Net income	150					150
Ending balance (in shares) at Mar. 31, 2023			203,740
Ending balance at Mar. 31, 2023	$ 5,600		$ 0	$ 5,182		$ 488		$ (70)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash flows from operating activities:
Net income	$ 150	$ 75
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	126	101
Amortization of deferred commissions	106	83
Stock-based compensation	381	325
Deferred income taxes	7	(2)
Other	1	15
Changes in operating assets and liabilities, net of effect of business combinations:
Accounts receivable	619	562
Deferred commissions	(159)	(137)
Prepaid expenses and other assets	(64)	(46)
Accounts payable	(46)	69
Deferred revenue	40	21
Accrued expenses and other liabilities	(259)	(203)
Net cash provided by operating activities	902	863
Cash flows from investing activities:
Purchases of property and equipment	(165)	(93)
Purchases of investments	(1,222)	(662)
Purchases of non-marketable investments	(30)	(101)
Sales and maturities of investments	880	577
Other	13	(1)
Net cash used in investing activities	(524)	(280)
Cash flows from financing activities:
Repayments of convertible senior notes attributable to principal	0	(6)
Proceeds from employee stock plans	117	105
Taxes paid related to net share settlement of equity awards	(112)	(150)
Net cash provided by (used in) financing activities	5	(51)
Foreign currency effect on cash, cash equivalents and restricted cash	1	(5)
Net change in cash, cash equivalents and restricted cash	384	527
Cash, cash equivalents and restricted cash at beginning of period	1,475	1,732
Cash, cash equivalents and restricted cash at end of period	1,859	2,259
Cash, cash equivalents and restricted cash at end of period:
Cash and cash equivalents	1,852	2,252
Restricted cash included in prepaid expenses and other current assets	7	7
Total cash, cash equivalents and restricted cash shown in the condensed consolidated statements of cash flows	1,859	2,259
Supplemental disclosures of other cash flow information:
Interest paid	11	11
Income taxes paid, net of refunds	22	9
Non-cash investing and financing activities:
Settlement of 2022 Notes conversion feature	0	21
Benefit from exercise of 2022 Note Hedge	0	21
Property and equipment included in accounts payable, accrued expenses and other liabilities	$ 47	$ 73

Description of the Business

Description of the Business	3 Months Ended
	Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of the Business	Description of the BusinessServiceNow was founded on a simple premise: a better technology platform will help work flow better. We help global enterprises across industries, universities and governments to digitize their workflows. We organize our workflow applications along four primary areas: Technology, Customer and Industry, Employee and Creator. The products under each of our workflows help customers connect, automate and empower work across systems and silos to enable great outcomes for businesses and great experiences for people. The Now Platform integrates with our customers’ cloud platforms and systems of choice, allowing our customers to deliver workflows across their current and future preferred systems of record and collaboration platforms.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements due to the permitted exclusion of certain disclosures for interim reporting. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary under GAAP for fair statement of results for the interim periods presented have been included. As a result of displaying amounts in millions, rounding differences may exist in the condensed consolidated financial statements and footnote tables. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for other interim periods or future years. The condensed consolidated balance sheet as of December 31, 2022 is derived from audited consolidated financial statements; however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on January 31, 2023. Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, and include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Such management estimates and assumptions include, but are not limited to, standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred commissions, valuation of intangible assets, the useful life of property and equipment and identifiable intangible assets, stock-based compensation expense and income taxes. Actual results could differ from those estimates. Significant Accounting Policies There were no significant changes to our significant accounting policies disclosed in “Note 2 – Summary of Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on January 31, 2023. Concentration of Credit Risk and Significant Customers Credit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. As of March 31, 2023 and December 31, 2022, there were no customers that represented more than 10% of our accounts receivable balance. There were no customers that individually exceeded 10% of our total revenues in any of the periods presented. For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer. Prior Period Reclassifications Certain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications did not result in a restatement of prior period condensed consolidated financial statements.

Investments

Investments	3 Months Ended
	Mar. 31, 2023
Debt Securities, Available-for-Sale [Abstract]
Investments	Investments Marketable Debt Securities The following is a summary of our available-for-sale debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in millions): March 31, 2023 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 647 $ — $ (1) $ 646 Corporate notes and bonds 3,332 3 (41) 3,294 Certificates of deposit 169 — — 169 U.S. government and agency securities 1,105 2 (1) 1,106 Mortgage-backed and asset-backed securities 102 — (16) 86 Total available-for-sale securities $ 5,355 $ 5 $ (59) $ 5,301 December 31, 2022 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 558 $ — $ (2) $ 556 Corporate notes and bonds 3,414 — (52) 3,362 Certificates of deposit 162 — — 162 U.S. government and agency securities 768 — (2) 766 Mortgage-backed and asset-backed securities 98 — (17) 81 Total available-for-sale securities $ 5,000 $ — $ (73) $ 4,927 As of March 31, 2023, the contractual maturities of our available-for-sale debt securities, excluding those securities classified within cash and cash equivalents on the condensed consolidated balance sheet and mortgage-backed and asset-backed securities that do not have a single maturity, did not exceed 36 months. The fair values of available-for-sale securities, by remaining contractual maturity, are as follows (in millions): March 31, 2023 Due within 1 year $ 3,062 Due in 1 year through 5 years 2,153 Instruments not due in single maturity 86 Total $ 5,301 As of March 31, 2023 and December 31, 2022, the fair value of available-for-sale securities in a continuous unrealized loss position totaled $3,841 million and $4,232 million, respectively, the majority of which has been in a continuous unrealized loss position for greater than 12 months. The decline in fair value below amortized cost basis was not considered other than temporary as it is more likely than not we will hold the securities until maturity or a recovery of the cost basis, and credit-related impairment losses were not material as of March 31, 2023. Non-Marketable Equity Investments As of March 31, 2023 and December 31, 2022, the total amount of non-marketable equity investments in privately held companies included in other assets on our condensed consolidated balance sheets was $277 million and $252 million, respectively. These balances include a $100 million investment in the common and preferred shares of Celonis SE, a privately held company that develops and sells process mining software. Our non-marketable equity investments are accounted for using the measurement alternative, which measures the investments at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes resulting from the issuance of similar or identical securities in an orderly transaction by the same issuer. Determining whether an observed transaction is similar to a security within our portfolio requires judgment based on the rights and preferences of the securities. Recording upward and downward adjustments to the carrying value of our non-marketable equity investments as a result of observable price changes requires quantitative assessments of the fair value of our non-marketable equity investments using various valuation methodologies and involves the use of estimates. We classify these fair value measurements as Level 3 within the fair value hierarchy.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of March 31, 2023 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 1,176 $ — $ 1,176 Commercial paper — 88 88 Corporate notes and bonds — 8 8 Deposits 125 — 125 Marketable securities: Commercial paper — 646 646 Corporate notes and bonds — 3,294 3,294 Certificates of deposit — 169 169 U.S. government and agency securities — 1,106 1,106 Mortgage-backed and asset-backed securities — 86 86 Total $ 1,301 $ 5,397 $ 6,698 The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of December 31, 2022 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 738 $ — $ 738 Commercial paper — 36 36 Corporate notes and bonds — 10 10 Certificates of deposit — 2 2 Deposits 124 — 124 U.S. government and agency securities — 8 8 Marketable securities: Commercial paper — 556 556 Corporate notes and bonds — 3,362 3,362 Certificates of deposit — 162 162 U.S. government and agency securities — 766 766 Mortgage-backed and asset-backed securities — 81 81 Total $ 862 $ 4,983 $ 5,845 We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs), pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) or using unobservable inputs that are supported by little or no market activity (Level 3 inputs). Our non-marketable equity investments are not included in the table above and are discussed in Note 3. See Note 7 for the fair value measurement of our derivative contracts and Note 9 for the fair value measurement of our long-term debt, which are also not included in the table above. Our marketable equity investments are classified within Level 1 and are immaterial as of March 31, 2023 and December 31, 2022.

Business Combinations

Business Combinations	3 Months Ended
	Mar. 31, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations	Business Combinations 2022 Business Combinations During the year ended December 31, 2022, we completed certain acquisitions for total purchase consideration of $92 million primarily to enhance our products with the acquired technology and engineering workforce. The acquisitions were not material to our consolidated financial statements, either individually or in the aggregate. 2021 Business Combinations On June 15, 2021, we acquired Lightstep, Inc., a leading observability solution provider, for $512 million in a cash transaction. The purchase price was allocated based on the estimated fair value of developed technology intangible asset of $85 million (five-year estimated useful life), customer-related and brand assets of $11 million, net tangible assets of $8 million, deferred tax liabilities of $6 million and goodwill of $413 million, which is not deductible for income tax purposes. On January 8, 2021, we acquired all outstanding stock of Element AI Inc., a leading enterprise artificial intelligence solution provider, for $228 million in an all-cash transaction. The purchase price was allocated based on the estimated fair value of developed technology intangible asset of $85 million (five-year estimated useful life), net tangible assets of $16 million and goodwill of $81 million, which is partially deductible for income tax purposes. At time of acquisition, we established an unrecognized tax benefit of $43 million on pre-acquisition net operating loss carryforwards and other tax attributes which was subsequently released resulting in establishment of deferred tax asset based on completion of valuation and filing certain tax returns in the third quarter of 2021. Goodwill is primarily attributed to the value expected from synergies resulting from the business combinations. The fair values assigned to tangible and intangible assets acquired, liabilities assumed and income taxes payable and deferred taxes are based on management’s estimates and assumptions. The Company finalized the fair value measurements within one year from the acquisition date. During the year ended December 31, 2021, we also completed certain acquisitions for total purchase consideration of $66 million primarily to enhance our products with the acquired technology and engineering workforce. These acquisitions were not material to our consolidated financial statements, either individually or in the aggregate. We have included the financial results of business combinations in the consolidated financial statements from the respective dates of acquisition, which were not material. Pro forma revenue and earnings amounts on a combined basis have not been presented as it is impracticable due to the lack of availability of historical financial statements that comply with GAAP. Aggregate acquisition-related costs associated with business combinations are [not material] for the three months ended March 31, 2023 and 2022, respectively, and are included in general and administrative expenses in our condensed consolidated statements of comprehensive income as incurred.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Intangible assets consist of the following (in millions): March 31, 2023 December 31, 2022 Developed technology $ 436 $ 434 Patents 72 72 Other 15 15 Intangible assets, gross 523 521 Less: accumulated amortization (311) (289) Intangible assets, net $ 212 $ 232 The weighted-average useful life of the acquired developed technology for the three months ended March 31, 2023 and 2022 was approximately five years. Amortization expense for intangible assets for each of the three months ended March 31, 2023 and 2022 was $20 million. The following table presents the estimated future amortization expense related to intangible assets held at March 31, 2023 (in millions): Years Ending December 31, Remainder of 2023 $ 58 2024 72 2025 51 2026 20 2027 6 Thereafter 5 Total future amortization expense $ 212

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment, net consists of the following (in millions): March 31, 2023 December 31, 2022 Computer equipment $ 1,714 $ 1,606 Computer software 89 82 Leasehold and other improvements 226 226 Furniture and fixtures 80 81 Construction in progress 69 53 Property and equipment, gross 2,178 2,048 Less: Accumulated depreciation (1,061) (995) Property and equipment, net $ 1,117 $ 1,053

Derivative Contracts

Derivative Contracts	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Contracts	Derivative Contracts As of March 31, 2023 and December 31, 2022, we had foreign currency forward contracts with total notional values of $1,556 million and $1,360 million, respectively, which are not designated as hedging instruments. Our foreign currency forward contracts are classified within Level 2 as the valuation inputs are based on quoted prices and market observable data of similar instruments in active markets, such as currency spot and forward rates. Outstanding foreign currency forward contracts are recorded at gross fair value as prepaid expenses and other current assets as well as accrued expenses and other current liabilities on the condensed consolidated balance sheets. The gross fair value of these foreign currency forward contracts was immaterial as of March 31, 2023 and December 31, 2022. The gains (losses) recognized for these foreign currency forward contracts were immaterial for each of the three months ended March 31, 2023 and 2022.

Deferred Revenue and Performanc

Deferred Revenue and Performance Obligations	3 Months Ended
	Mar. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred Revenue and Performance Obligations	Deferred Revenue and Performance Obligations Revenues recognized during the three months ended March 31, 2023 from amounts included in deferred revenue as of December 31, 2022 were $1.8 billion. Revenues recognized during the three months ended March 31, 2022 from amounts included in deferred revenue as of December 31, 2021 were $1.4 billion. Remaining Performance Obligations Transaction price allocated to remaining performance obligations (“RPO”) represents contracted revenue that has not yet been recognized, which includes deferred revenue and non-cancellable amounts that will be invoiced and recognized as revenues in future periods. RPO excludes contracts that are billed in arrears, such as certain time and materials contracts, as we apply the “right to invoice” practical expedient under relevant accounting guidance. As of March 31, 2023, the total non-cancellable RPO under our contracts with customers was $14.0 billion and we expect to recognize revenues on approximately 50% of these RPO over the following 12 months. The majority of the non-current RPO will be recognized over the next 13 to 36 months.

Debt

Debt	3 Months Ended
	Mar. 31, 2023
Convertible Notes Payable [Abstract]
Debt	Debt The carrying value of our outstanding debt, net of unamortized debt discount and issuance costs of $14 million, was $1,486 million for each of the periods ended March 31, 2023 and December 31, 2022. We consider the fair value of the 2030 Notes at March 31, 2023 and December 31, 2022 to be a Level 2 measurement. The estimated fair value of the 2030 Notes based on the closing trading price per $100, was $1,211 million and $1,144 million at March 31, 2023 and December 31, 2022, respectively. 2030 Notes In August 2020, we issued 1.40% fixed rate ten-year notes with an aggregate principal amount of $1.5 billion due on September 1, 2030 (the “2030 Notes”). The 2030 Notes were issued at 99.63% of principal and we incurred approximately $13 million for debt issuance costs. The effective interest rate for the 2030 Notes was 1.53% and included interest payable, amortization of debt issuance cost and amortization of debt discount, as applicable. Interest is payable semi-annually in arrears on March 1 and September 1 of each year, beginning on March 1, 2021, and the entire outstanding principal amount is due at maturity on September 1, 2030. The 2030 Notes are unsecured obligations and the indentures governing the 2030 Notes contain customary events of default and covenants that, among others and subject to exceptions, restrict the Company’s ability to incur or guarantee debt secured by liens on specified assets or enter into sale and lease-back transactions with respect to specified properties. 2022 Notes, Note Hedge and Warrants In May and June 2017, we issued an aggregate of $782.5 million of 0% convertible senior notes (the “2022 Notes”), which were converted prior to or settled on June 1, 2022, in accordance with their terms. Convertible Date Initial Conversion Price per Share Initial Conversion Rate per $1,000 Par Value Initial Number of Shares (in millions) 2022 Notes February 1, 2022 $ 134.75 7.42 shares 6 To minimize the impact of potential economic dilution upon conversion of the 2022 Notes, we entered into convertible note hedge transactions (the “2022 Note Hedge”) with certain investment banks, with respect to our common stock concurrently with the issuance of the 2022 Notes. The 2022 Note Hedge offset the dilution and cash payments in excess of the principal amount of the converted 2022 Notes and expired upon the maturity date of the 2022 Notes, which was on June 1, 2022. Purchase Initial Shares Shares as of March 31, 2023 (in millions) 2022 Note Hedge $ 128 6 — Separately, we entered into warrant transactions with certain investment banks, whereby we sold warrants to acquire 6 million shares of our common stock with aggregate proceeds of $54 million (the “2022 Warrants”). The 2022 Warrants were separate transactions and were not remeasured through earnings each reporting period. The 2022 Warrants were not part of the 2022 Notes or 2022 Note Hedge. During the quarter ended June 30, 2022, we entered into unwind agreements to settle the remaining portion of the 2022 Warrants by delivering an aggregate of 0.6 million shares of our common stock. Accordingly, the 2022 Warrants were no longer outstanding as of June 30, 2022.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Loss The following table shows the components of accumulated other comprehensive loss, net of tax, in the stockholders’ equity section of our condensed consolidated balance sheets (in millions): March 31, 2023 December 31, 2022 Foreign currency translation adjustment $ (12) $ (25) Net unrealized loss on investments (58) (77) Accumulated other comprehensive loss $ (70) $ (102) Reclassification adjustments out of accumulated other comprehensive loss into net income were not material for all periods presented.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Common Stock We are authorized to issue a total of 600 million shares of common stock as of March 31, 2023. Holders of our common stock are not entitled to receive dividends unless declared by our board of directors. As of March 31, 2023, we had 203.7 million shares of common stock outstanding and had reserved shares of common stock for future issuance as follows (in thousands): March 31, 2023 Stock plans: Options outstanding 1,233 RSUs (1) 8,421 Shares of common stock available for future grants: 2021 Equity Incentive Plan (2) 1,966 Amended and Restated 2012 Employee Stock Purchase Plan (2) 8,693 2022 New-Hire Equity Incentive Plan (2) 869 Total shares of common stock reserved for future issuance 21,182 (1) Represents the number of shares issuable upon settlement of outstanding restricted stock units (“RSUs”) and performance-based RSUs (“PRSUs”), as discussed in Note 12. (2) Refer to Note 12 for a description of these plans. During the three months ended March 31, 2023 and 2022, we issued a total of 0.9 million shares and 0.8 million shares, respectively, from stock option exercises, vesting of RSUs, net of employee payroll taxes, and purchases from the employee stock purchase plan (“ESPP”).

Equity Awards

Equity Awards	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Equity Awards	Equity Awards We currently have three equity incentive plans: 2012 Equity Incentive Plan (the “2012 Plan”), 2021 Equity Incentive Plan (the “2021 Plan”) and 2022 New-Hire Equity Incentive Plan (the “2022 Plan”). The 2012 Plan was terminated in connection with the approval of the 2021 Plan on June 7, 2021 but continues to govern the terms of outstanding equity awards that were granted prior to the termination of the 2012 Plan. As of June 7, 2021, we no longer grant equity awards pursuant to the 2012 Plan. On November 7, 2022, the 2022 Plan was approved for newly hired employees prospectively. The 2021 Plan and the 2012 Plan provide for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, RSUs, performance-based stock awards and other forms of equity compensation (collectively, “equity awards”). The 2022 Plan permits the grant of any of the foregoing awards with the exception of incentive stock options. In addition, the 2022 Plan, the 2021 Plan and the 2012 Plan provide for the grant of performance cash awards. Incentive stock options may be granted only to employees. All other equity awards may be granted to employees, including officers, as well as directors and consultants. Our Amended and Restated 2012 Employee Stock Purchase Plan (the “2012 ESPP”) authorizes the issuance of shares of common stock pursuant to purchase rights granted to our employees. The price at which common stock is purchased under the 2012 ESPP is equal to 85% of the fair market value of our common stock on the first or last day of the offering period, whichever is lower. Offering periods are six months long and begin on February 1 and August 1 of each year. The number of shares of common stock reserved for issuance will not be increased without shareholder approval. Stock Options A summary of stock option activity for the three months ended March 31, 2023 was as follows: Number of Weighted- Weighted- Aggregate (in thousands) (in years) (in millions) Outstanding at December 31, 2022 1,237 $ 590.36 Exercised (4) $ 71.26 $ 1 Forfeited — $ 84.97 Outstanding at March 31, 2023 1,233 $ 591.98 8.1 $ 58 Vested and expected to vest as of March 31, 2023 965 $ 572.11 8.0 $ 56 Vested and exercisable as of March 31, 2023 149 $ 171.79 5.1 $ 44 Aggregate intrinsic value represents the difference between the estimated fair value of our common stock and the exercise price of outstanding, in-the-money options. The total intrinsic value for stock options exercised for the three months ended March 31, 2023 and 2022 was $1 million and $22 million, respectively. The total fair value of stock options vested during the three months ended March 31, 2023 and 2022 was $2 million and $3 million, respectively. The weighted-average grant-date fair value of stock options granted during the three months ended March 31, 2022 was $273.63 per share. No stock options were granted during the three months ended March 31, 2023. As of March 31, 2023, total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested stock options was approximately $66 million. The weighted-average remaining vesting period of unvested stock options at March 31, 2023 was approximately one year. RSUs A summary of RSU activity for the three months ended March 31, 2023 was as follows: Number of Weighted-Average Grant-Date Fair Value (in thousands) Outstanding at December 31, 2022 5,737 $ 505.79 Granted 3,590 $ 465.57 Vested (797) $ 448.61 Forfeited (109) $ 504.48 Outstanding at March 31, 2023 8,421 $ 494.49 Expected to vest as of March 31, 2023 7,210 RSUs outstanding as of March 31, 2023 were comprised of 7.8 million RSUs with only service conditions and 0.6 million RSUs with both service and performance conditions, including certain RSUs with additional market conditions. The total intrinsic value of the RSUs vested was $362 million and $494 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, the aggregate intrinsic value of RSUs outstanding was $3.9 billion and RSUs expected to vest was $3.4 billion. The weighted-average grant-date fair value of RSUs granted was $465.57 and $589.15 per share for the three months ended March 31, 2023 and 2022, respectively. PRSUs with service, performance and market vesting criteria are considered as eligible to vest when approved by the compensation committee of our board of directors in January of the year following the grant. The ultimate number of shares eligible to vest for PRSUs range from 0% to 200% of the target number of shares depending on achievement relative to the performance metrics and, for certain PRSUs, depend on our total shareholder return relative to that of the S&P 500 index over the applicable measurement period. The eligible shares subject to PRSUs granted during the three months ended March 31, 2023 will vest in February of the following year and semi-annually for the remaining two years contingent on each holder’s continuous status as a service provider on the applicable vesting dates. The number of PRSUs granted included in the table above reflects the shares that could be eligible to vest at 100% of target for PRSUs and includes adjustments for over or under achievement for PRSUs granted in the prior year. We recognized $35 million and $29 million of stock-based compensation, net of actual and estimated forfeitures, associated with PRSUs on a graded vesting basis during the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested RSUs was approximately $3.2 billion, and the weighted-average remaining vesting period was approximately three years.

Net Income Per Share

Net Income Per Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share Basic net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net income per share is computed by dividing net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period, adjusted for the effects of dilutive shares of common stock, which are comprised of outstanding stock options, RSUs, ESPP obligations, the 2022 Notes and the 2022 Warrants. Stock awards with performance or market conditions are included in dilutive shares to the extent all conditions are met. The potentially dilutive shares of common stock are computed using the treasury stock method or the as-if converted method, as applicable. The effects of outstanding stock options, RSUs, ESPP obligations, 2022 Notes and 2022 Warrants are excluded from the computation of diluted net income per share in periods in which the effect would be antidilutive. The following tables present the calculation of basic and diluted net income per share attributable to common stockholders (in millions, except for number of shares reflected in thousands and per share data): Three Months Ended March 31, 2023 2022 Numerator: Net income $ 150 $ 75 Denominator: Weighted-average shares outstanding - basic 203,385 200,088 Weighted-average effect of potentially dilutive securities: Common stock options 109 180 RSUs 769 1,892 2022 Warrants — 640 Weighted-average shares outstanding - diluted 204,263 202,800 Net income per share - basic $ 0.74 $ 0.38 Net income per share - diluted $ 0.73 $ 0.37 Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands): Three Months Ended March 31, 2023 2022 Common stock options 1,028 1,022 RSUs 6,509 3,766 ESPP obligations 194 159 2022 Notes — 689 Total potentially dilutive securities 7,731 5,636

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes We compute our provision for income taxes by applying the estimated annual effective tax rate to year-to-date income from recurring operations and adjust the provision for discrete tax items recorded in the period. Our income tax provision was $38 million for the three months ended March 31, 2023. The income tax provision was primarily attributable to the mix of earnings and losses in countries with differing statutory tax rates and the valuation allowance in the United States. Our income tax provision was $10 million for the three months ended March 31, 2022. The income tax provision was primarily attributable to the mix of earnings and losses in countries with differing statutory tax rates and the valuation allowance in the United States. We maintain a full valuation allowance against our U.S. federal and state deferred tax assets. We regularly assess the need for a valuation allowance against our deferred tax assets. In making that assessment, we consider both positive and negative evidence related to the likelihood of realization of the deferred tax assets to determine, based on the weight of available evidence, whether it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022, the three-year cumulative U.S. pre-tax income of $338 million was offset by the three-year total U.S. permanent differences and other comprehensive losses of approximately $720 million, resulting in a three-year cumulative U.S. loss of approximately $380 million. Due to the cumulative U.S. losses during the prior twelve quarters, including permanent differences and other comprehensive losses, and based on all available positive and negative evidence, as of March 31, 2023 and December 31, 2022, we have determined that it is more likely than not that our U.S. deferred tax assets will not be realized. However, given our current U.S. earnings and anticipated future earnings, we believe there is a reasonable possibility that prior to the fourth quarter of 2023 sufficient positive evidence of sustained U.S. profitability may become available to allow us to reach a conclusion that the U.S. valuation allowance will no longer be needed. Release of the valuation allowance would result in the recognition of material U.S. federal and state deferred tax assets and a corresponding decrease to income tax expense estimated to be $1.0 billion to $1.2 billion in the fiscal year the release is recorded. The exact timing and amount of the valuation allowance release are subject to change based on the level of sustained U.S. profitability the Company is able to actually achieve. We are subject to taxation in the United States and foreign jurisdictions. As of March 31, 2023, our tax years 2004 to 2022 remain subject to examination in most jurisdictions.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Operating Leases For some of our offices and data centers, we have entered into non-cancellable operating lease agreements with various expiration dates through 2035. Certain lease agreements include options to renew or terminate the lease, which are not reasonably certain to be exercised and therefore are not factored into our determination of lease payments. Total operating lease costs were $31 million and $27 million, excluding short-term lease costs, variable lease costs and sublease income, each of which were immaterial, for the three months ended March 31, 2023 and 2022, respectively. For each of the three months ended March 31, 2023 and 2022, total cash paid for amounts included in the measurement of operating lease liabilities was $19 million. Operating lease liabilities arising from obtaining operating right-of-use assets totaled $24 million and $15 million for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023, the weighted-average remaining lease term is approximately nine years, and the weighted-average discount rate is 4%. Maturities of operating lease liabilities as of March 31, 2023 are presented in the table below (in millions): Remainder of 2023 $ 89 2024 100 2025 104 2026 85 2027 75 Thereafter 448 Total operating lease payments 901 Less: imputed interest (149) Present value of operating lease liabilities $ 752 In addition to the amounts above, as of March 31, 2023, we have operating leases, primarily for offices, that have not yet commenced with undiscounted cash flows of $70 million. These operating leases are expected to commence in 2023 with lease terms of twelve years. Other Commitments Other contractual commitments consist of data center and IT operations and sales and marketing activities related to our daily business operations. There were no material contractual obligations that were entered into during the three months ended March 31, 2023 that were outside the ordinary course of business. During the three months ended September 30, 2022, we entered into a non-cancellable, $500 million agreement with Microsoft to purchase cloud services over five years, as we accelerate Azure adoption for mutual customers. In addition to the amounts above, the repayment of our 2030 Notes with an aggregate principal amount of $1.5 billion is due on September 1, 2030. Refer to Note 9 for further information regarding our 2030 Notes. Further, $33 million of unrecognized tax benefits have been recorded as liabilities as of March 31, 2023. Legal Proceedings From time to time, we are party to litigation and other legal proceedings in the ordinary course of business. While the results of any litigation or other legal proceedings are uncertain, management does not believe the ultimate resolution of any pending legal matters is likely to have a material adverse effect on our financial position, results of operations or cash flows, except for those matters for which we have recorded a loss contingency. We accrue for loss contingencies when it is both probable that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. Generally, our subscription agreements require us to defend our customers for third-party intellectual property infringement and other claims. Any adverse determination related to intellectual property claims or other litigation could prevent us from offering our services and adversely affect our financial condition and results of operations. Indemnification Provisions Our agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, we have entered into indemnification agreements with our directors, executive officers and certain other officers that will require us, among other things, to indemnify them against certain liabilities that may arise as a result of their affiliation with us. We have not incurred any costs as a result of such indemnification obligations and have not recorded any liabilities related to such obligations in the condensed consolidated financial statements.

Information about Geographic Ar

Information about Geographic Areas and Products	3 Months Ended
	Mar. 31, 2023
Segments, Geographical Areas [Abstract]
Information about Geographic Areas and Products	Information about Geographic Areas and Products Revenues by geographic area, based on the location of our users, were as follows for the periods presented (in millions): Three Months Ended March 31, 2023 2022 North America (1) $ 1,344 $ 1,116 EMEA (2) 532 434 Asia Pacific and other 220 172 Total revenues $ 2,096 $ 1,722 Property and equipment, net by geographic area were as follows (in millions): March 31, 2023 December 31, 2022 North America (3) $ 720 $ 664 EMEA (2) 220 221 Asia Pacific and other $ 177 $ 168 Total property and equipment, net $ 1,117 $ 1,053 (1) Revenues attributed to the United States were 94% of North America revenues for each of the three months ended March 31, 2023 and 2022. (2) Europe, the Middle East and Africa (“EMEA”). (3) Property and equipment, net attributed to the United States were approximately 83% and 85% of property and equipment, net attributable to North America as of March 31, 2023 and December 31, 2022, respectively. . Subscription revenues consist of the following (in millions): Three Months Ended March 31, 2023 2022 Digital workflow products $ 1,790 $ 1,440 ITOM products 234 191 Total subscription revenues $ 2,024 $ 1,631

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements and condensed footnotes have been prepared in accordance with the applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Accordingly, they do not include all of the information and footnotes required by U.S. generally accepted accounting principles (“GAAP”) for complete financial statements due to the permitted exclusion of certain disclosures for interim reporting. In the opinion of management, all adjustments (consisting of normal recurring items) considered necessary under GAAP for fair statement of results for the interim periods presented have been included. As a result of displaying amounts in millions, rounding differences may exist in the condensed consolidated financial statements and footnote tables. The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for other interim periods or future years. The condensed consolidated balance sheet as of December 31, 2022 is derived from audited consolidated financial statements; however, it does not include all of the information and footnotes required by GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on January 31, 2023.
Principles of Consolidation	Principles of Consolidation The accompanying condensed consolidated financial statements have been prepared in conformity with GAAP, and include our accounts and the accounts of our wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated upon consolidation.
Use of Estimates	Use of EstimatesThe preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as reported amounts of revenues and expenses during the reporting period. Such management estimates and assumptions include, but are not limited to, standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations, the period of benefit for deferred commissions, valuation of intangible assets, the useful life of property and equipment and identifiable intangible assets, stock-based compensation expense and income taxes. Actual results could differ from those estimates.
Concentration of Credit Risk and Significant Customers	Concentration of Credit Risk and Significant Customers Credit risk arising from accounts receivable is mitigated to a certain extent due to our large number of customers and their dispersion across various industries and geographies. As of March 31, 2023 and December 31, 2022, there were no customers that represented more than 10% of our accounts receivable balance. There were no customers that individually exceeded 10% of our total revenues in any of the periods presented. For purposes of assessing concentration of credit risk and significant customers, a group of customers under common control or customers that are affiliates of each other are regarded as a single customer.
Fair Value Measurements	We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs), pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) or using unobservable inputs that are supported by little or no market activity (Level 3 inputs).
Legal Proceedings	Legal Proceedings From time to time, we are party to litigation and other legal proceedings in the ordinary course of business. While the results of any litigation or other legal proceedings are uncertain, management does not believe the ultimate resolution of any pending legal matters is likely to have a material adverse effect on our financial position, results of operations or cash flows, except for those matters for which we have recorded a loss contingency. We accrue for loss contingencies when it is both probable that we will incur the loss and when we can reasonably estimate the amount of the loss or range of loss. Generally, our subscription agreements require us to defend our customers for third-party intellectual property infringement and other claims. Any adverse determination related to intellectual property claims or other litigation could prevent us from offering our services and adversely affect our financial condition and results of operations. Indemnification Provisions Our agreements include provisions indemnifying customers against intellectual property and other third-party claims. In addition, we have entered into indemnification agreements with our directors, executive officers and certain other officers that will require us, among other things, to indemnify them against certain liabilities that may arise as a result of their affiliation with us. We have not incurred any costs as a result of such indemnification obligations and have not recorded any liabilities related to such obligations in the condensed consolidated financial statements.
Prior Period Reclassifications	Prior Period ReclassificationsCertain prior period amounts have been reclassified to conform to the current period presentation. These reclassifications did not result in a restatement of prior period condensed consolidated financial statements

Investments (Tables)

Investments (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Securities, Available-for-Sale [Abstract]
Schedule of Marketable Debt Securities	The following is a summary of our available-for-sale debt securities recorded within short-term and long-term investments on the condensed consolidated balance sheets (in millions): March 31, 2023 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 647 $ — $ (1) $ 646 Corporate notes and bonds 3,332 3 (41) 3,294 Certificates of deposit 169 — — 169 U.S. government and agency securities 1,105 2 (1) 1,106 Mortgage-backed and asset-backed securities 102 — (16) 86 Total available-for-sale securities $ 5,355 $ 5 $ (59) $ 5,301 December 31, 2022 Amortized Gross Gross Estimated Available-for-sale securities: Commercial paper $ 558 $ — $ (2) $ 556 Corporate notes and bonds 3,414 — (52) 3,362 Certificates of deposit 162 — — 162 U.S. government and agency securities 768 — (2) 766 Mortgage-backed and asset-backed securities 98 — (17) 81 Total available-for-sale securities $ 5,000 $ — $ (73) $ 4,927
Investments Classified by Contractual Maturity Date	The fair values of available-for-sale securities, by remaining contractual maturity, are as follows (in millions): March 31, 2023 Due within 1 year $ 3,062 Due in 1 year through 5 years 2,153 Instruments not due in single maturity 86 Total $ 5,301

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Assets Measured at Fair Value on Recurring Basis	The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of March 31, 2023 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 1,176 $ — $ 1,176 Commercial paper — 88 88 Corporate notes and bonds — 8 8 Deposits 125 — 125 Marketable securities: Commercial paper — 646 646 Corporate notes and bonds — 3,294 3,294 Certificates of deposit — 169 169 U.S. government and agency securities — 1,106 1,106 Mortgage-backed and asset-backed securities — 86 86 Total $ 1,301 $ 5,397 $ 6,698 The following table presents our fair value hierarchy for our assets measured at fair value on a recurring basis as of December 31, 2022 (in millions): Level 1 Level 2 Total Cash equivalents: Money market funds $ 738 $ — $ 738 Commercial paper — 36 36 Corporate notes and bonds — 10 10 Certificates of deposit — 2 2 Deposits 124 — 124 U.S. government and agency securities — 8 8 Marketable securities: Commercial paper — 556 556 Corporate notes and bonds — 3,362 3,362 Certificates of deposit — 162 162 U.S. government and agency securities — 766 766 Mortgage-backed and asset-backed securities — 81 81 Total $ 862 $ 4,983 $ 5,845

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangible Assets	Intangible assets consist of the following (in millions): March 31, 2023 December 31, 2022 Developed technology $ 436 $ 434 Patents 72 72 Other 15 15 Intangible assets, gross 523 521 Less: accumulated amortization (311) (289) Intangible assets, net $ 212 $ 232
Schedule of Estimated Future Amortization Expense Related to Intangible Assets	The following table presents the estimated future amortization expense related to intangible assets held at March 31, 2023 (in millions): Years Ending December 31, Remainder of 2023 $ 58 2024 72 2025 51 2026 20 2027 6 Thereafter 5 Total future amortization expense $ 212

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Summary of Property and Equipment, Net	Property and equipment, net consists of the following (in millions): March 31, 2023 December 31, 2022 Computer equipment $ 1,714 $ 1,606 Computer software 89 82 Leasehold and other improvements 226 226 Furniture and fixtures 80 81 Construction in progress 69 53 Property and equipment, gross 2,178 2,048 Less: Accumulated depreciation (1,061) (995) Property and equipment, net $ 1,117 $ 1,053

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2023
Convertible Notes Payable [Abstract]
Summary of Convertible Senior Notes	Convertible Date Initial Conversion Price per Share Initial Conversion Rate per $1,000 Par Value Initial Number of Shares (in millions) 2022 Notes February 1, 2022 $ 134.75 7.42 shares 6
Schedule of Note Hedges	Purchase Initial Shares Shares as of March 31, 2023 (in millions) 2022 Note Hedge $ 128 6 —

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income, Net of Tax	The following table shows the components of accumulated other comprehensive loss, net of tax, in the stockholders’ equity section of our condensed consolidated balance sheets (in millions): March 31, 2023 December 31, 2022 Foreign currency translation adjustment $ (12) $ (25) Net unrealized loss on investments (58) (77) Accumulated other comprehensive loss $ (70) $ (102)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Common Stock Outstanding and Reserved Shares of Common Stock for Future Issuance	As of March 31, 2023, we had 203.7 million shares of common stock outstanding and had reserved shares of common stock for future issuance as follows (in thousands): March 31, 2023 Stock plans: Options outstanding 1,233 RSUs (1) 8,421 Shares of common stock available for future grants: 2021 Equity Incentive Plan (2) 1,966 Amended and Restated 2012 Employee Stock Purchase Plan (2) 8,693 2022 New-Hire Equity Incentive Plan (2) 869 Total shares of common stock reserved for future issuance 21,182 (1) Represents the number of shares issuable upon settlement of outstanding restricted stock units (“RSUs”) and performance-based RSUs (“PRSUs”), as discussed in Note 12. (2) Refer to Note 12 for a description of these plans.

Equity Awards (Tables)

Equity Awards (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	A summary of stock option activity for the three months ended March 31, 2023 was as follows: Number of Weighted- Weighted- Aggregate (in thousands) (in years) (in millions) Outstanding at December 31, 2022 1,237 $ 590.36 Exercised (4) $ 71.26 $ 1 Forfeited — $ 84.97 Outstanding at March 31, 2023 1,233 $ 591.98 8.1 $ 58 Vested and expected to vest as of March 31, 2023 965 $ 572.11 8.0 $ 56 Vested and exercisable as of March 31, 2023 149 $ 171.79 5.1 $ 44
Schedule of Restricted Stock Unit Activity	A summary of RSU activity for the three months ended March 31, 2023 was as follows: Number of Weighted-Average Grant-Date Fair Value (in thousands) Outstanding at December 31, 2022 5,737 $ 505.79 Granted 3,590 $ 465.57 Vested (797) $ 448.61 Forfeited (109) $ 504.48 Outstanding at March 31, 2023 8,421 $ 494.49 Expected to vest as of March 31, 2023 7,210

Net Income Per Share (Tables)

Net Income Per Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Income Per Share	The following tables present the calculation of basic and diluted net income per share attributable to common stockholders (in millions, except for number of shares reflected in thousands and per share data): Three Months Ended March 31, 2023 2022 Numerator: Net income $ 150 $ 75 Denominator: Weighted-average shares outstanding - basic 203,385 200,088 Weighted-average effect of potentially dilutive securities: Common stock options 109 180 RSUs 769 1,892 2022 Warrants — 640 Weighted-average shares outstanding - diluted 204,263 202,800 Net income per share - basic $ 0.74 $ 0.38 Net income per share - diluted $ 0.73 $ 0.37
Schedule of Potentially Dilutive Securities	Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands): Three Months Ended March 31, 2023 2022 Common stock options 1,028 1,022 RSUs 6,509 3,766 ESPP obligations 194 159 2022 Notes — 689 Total potentially dilutive securities 7,731 5,636

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Maturities of Operating Lease Liabilities	Maturities of operating lease liabilities as of March 31, 2023 are presented in the table below (in millions): Remainder of 2023 $ 89 2024 100 2025 104 2026 85 2027 75 Thereafter 448 Total operating lease payments 901 Less: imputed interest (149) Present value of operating lease liabilities $ 752

Information about Geographic _2

Information about Geographic Areas and Products (Tables)	3 Months Ended
	Mar. 31, 2023
Segments, Geographical Areas [Abstract]
Revenues by Geographic Area, Based on Billing Location of Customer	Revenues by geographic area, based on the location of our users, were as follows for the periods presented (in millions): Three Months Ended March 31, 2023 2022 North America (1) $ 1,344 $ 1,116 EMEA (2) 532 434 Asia Pacific and other 220 172 Total revenues $ 2,096 $ 1,722
Schedule of Long Lived Assets by Geographic Area	Property and equipment, net by geographic area were as follows (in millions): March 31, 2023 December 31, 2022 North America (3) $ 720 $ 664 EMEA (2) 220 221 Asia Pacific and other $ 177 $ 168 Total property and equipment, net $ 1,117 $ 1,053 (1) Revenues attributed to the United States were 94% of North America revenues for each of the three months ended March 31, 2023 and 2022. (2) Europe, the Middle East and Africa (“EMEA”). (3) Property and equipment, net attributed to the United States were approximately 83% and 85% of property and equipment, net attributable to North America as of March 31, 2023 and December 31, 2022, respectively. .
Schedule of Subscription Revenue	Subscription revenues consist of the following (in millions): Three Months Ended March 31, 2023 2022 Digital workflow products $ 1,790 $ 1,440 ITOM products 234 191 Total subscription revenues $ 2,024 $ 1,631

Investments - Summary of Invest

Investments - Summary of Investments (Detail) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 5,355	$ 5,000
Gross Unrealized Gains	5	0
Gross Unrealized Losses	(59)	(73)
Estimated Fair Value	5,301	4,927
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	647	558
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	(2)
Estimated Fair Value	646	556
Corporate notes and bonds
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	3,332	3,414
Gross Unrealized Gains	3	0
Gross Unrealized Losses	(41)	(52)
Estimated Fair Value	3,294	3,362
Certificates of deposit
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	169	162
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Estimated Fair Value	169	162
U.S. government and agency securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	1,105	768
Gross Unrealized Gains	2	0
Gross Unrealized Losses	(1)	(2)
Estimated Fair Value	1,106	766
Mortgage-backed and asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	102	98
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(16)	(17)
Estimated Fair Value	$ 86	$ 81

Investments - Narrative (Detail

Investments - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-Sale [Abstract]
Contractual maturities	36 months
Continuous unrealized loss position, fair value	$ 3,841	$ 4,232
Non-marketable equity investment	277	252
Celonis SE
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment	$ 100	$ 100

Investments - Maturities of Ava

Investments - Maturities of Available-for-Sale Investments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-Sale [Abstract]
Due within 1 year	$ 3,062
Due in 1 year through 5 years	2,153
Instruments not due in single maturity	86
Total	$ 5,301	$ 4,927

Fair Value Measurements (Detail

Fair Value Measurements (Detail) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 6,698	$ 5,845
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	1,301	862
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	5,397	4,983
Cash equivalents: | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	1,176	738
Cash equivalents: | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	88	36
Cash equivalents: | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	8	10
Cash equivalents: | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	125	124
Cash equivalents: | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		2
Cash equivalents: | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		8
Cash equivalents: | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	1,176	738
Cash equivalents: | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 1 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 1 | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	125	124
Cash equivalents: | Level 1 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		0
Cash equivalents: | Level 1 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		0
Cash equivalents: | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	88	36
Cash equivalents: | Level 2 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	8	10
Cash equivalents: | Level 2 | Deposits
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:	0	0
Cash equivalents: | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		2
Cash equivalents: | Level 2 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents:		8
Marketable securities: | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	646	556
Marketable securities: | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	3,294	3,362
Marketable securities: | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	169	162
Marketable securities: | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	1,106	81
Marketable securities: | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	86	766
Marketable securities: | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 1 | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	0	0
Marketable securities: | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	646	556
Marketable securities: | Level 2 | Corporate notes and bonds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	3,294	3,362
Marketable securities: | Level 2 | Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	169	162
Marketable securities: | Level 2 | U.S. government and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	1,106	81
Marketable securities: | Level 2 | Mortgage-backed and asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities:	$ 86	$ 766

Business Combinations (Details)

Business Combinations (Details) - USD ($) $ in Millions		3 Months Ended
	Jun. 15, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Business Acquisition [Line Items]
Goodwill		$ 823		$ 824
LightStep Inc.
Business Acquisition [Line Items]
Cash payment to acquire businesses	$ 512
Deferred tax liabilities	(6)
Net tangible assets	8
Goodwill	413
Developed technology
Business Acquisition [Line Items]
Weighted average useful life		5 years	5 years
Developed technology | LightStep Inc.
Business Acquisition [Line Items]
Intangible assets	85
Customer-related and brand assets | LightStep Inc.
Business Acquisition [Line Items]
Intangible assets	$ 11

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 523	$ 521
Less: accumulated amortization	(311)	(289)
Intangible assets, net	212	232
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	436	434
Patents
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	72	72
Other
Acquired Finite-Lived Intangible Assets [Line Items]
Intangible assets, gross	$ 15	$ 15

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization expense	$ 20	$ 20
Developed technology
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life	5 years	5 years

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Estimated Future Amortization of Intangible Assets (Details) $ in Millions	Mar. 31, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 58
2024	72
2025	51
2026	20
2027	6
Thereafter	5
Total future amortization expense	$ 212

Property and Equipment (Detail)

Property and Equipment (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,178		$ 2,048
Less: Accumulated depreciation	(1,061)		(995)
Property and equipment, net	1,117		1,053
Depreciation	81	$ 58
Computer equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	1,714		1,606
Computer software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	89		82
Leasehold and other improvements
Property, Plant and Equipment [Line Items]
Property and equipment, gross	226		226
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Property and equipment, gross	80		81
Construction in progress
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 69		$ 53

Property and Equipment - Narrat

Property and Equipment - Narrative - (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation	$ 81	$ 58

Derivative Contracts (Details)

Derivative Contracts (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Foreign currency derivative contracts | Not Designated as Hedging Instruments
Derivatives, Fair Value [Line Items]
Derivative, notional amount	$ 1,556	$ 1,360

Deferred Revenue and Performa_2

Deferred Revenue and Performance Obligations - Revenues Recognized from Deferred Revenues (Details) - USD ($) $ in Billions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ (1.8)	$ (1.4)

Deferred Revenue and Performa_3

Deferred Revenue and Performance Obligations - Transaction Price Allocated to the Remaining Performance Obligations (Details) $ in Billions	Mar. 31, 2023 USD ($)
Revenue from Contract with Customer [Abstract]
Remaining non-cancelable performance obligations	$ 14
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied (percent)	50%
Performance obligations period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied (percent)	48%
Performance obligations period	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | Minimum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations period	13 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 | Maximum
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations period	36 months

Debt - Narrative (Details)

Debt - Narrative (Details) $ / shares in Units, $ in Millions	1 Months Ended	3 Months Ended
	Aug. 31, 2020 USD ($)	Mar. 31, 2023 USD ($) $ / shares shares	Jun. 30, 2022 shares	Dec. 31, 2022 USD ($) $ / shares	Jun. 30, 2017 USD ($)
Debt Instrument [Line Items]
Estimated fair value of the note based on the closing trading price (in USD per share) | $ / shares		$ 100		$ 100
Shares (in shares) | shares			0
2022 convertible senior notes
Debt Instrument [Line Items]
Proceeds		$ 54
Initial shares (in shares) | shares		6,000,000
Common Stock
Debt Instrument [Line Items]
Settlement of 2022 warrants (in shares) | shares			600,000
2030 Notes
Debt Instrument [Line Items]
Unamortized debt discount and issuance costs, long-term		$ 14
Long-term debt		1,486
Contractual interest rate, notes	1.40%
Debt term	10 years
Face amount of debt	$ 1,500	$ 1,500
Percentage of principle issued	0.9963
Payments of debt issuance costs	$ 13
Effective interest rate		1.53%
2030 Notes | Level 2
Debt Instrument [Line Items]
Convertible debt, fair value disclosures		$ 1,211		$ 1,144
2022 Notes
Debt Instrument [Line Items]
Contractual interest rate, notes					0%
Face amount of debt					$ 782.5

Debt - Schedule of Conversion (

Debt - Schedule of Conversion (Details) - 2022 Notes shares in Millions	2 Months Ended
	Jun. 30, 2017 shares $ / shares
Debt Instrument [Line Items]
Initial conversion price per share (in USD per share) | $ / shares	$ 134.75
Initial conversion rate	0.00742
Initial number of shares (in shares) | shares	6

Debt - Schedule of Note Hedges

Debt - Schedule of Note Hedges (Details) - 2022 Note Hedge shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) shares
Derivative [Line Items]
Purchase | $	$ 128
Initial shares (in shares)	6
Shares (in shares)	0

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	$ 5,600	$ 5,032	$ 3,997	$ 3,695
Foreign currency translation adjustment
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(12)	(25)
Net unrealized loss on investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	(58)	(77)
Accumulated other comprehensive loss
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated other comprehensive loss	$ (70)	$ (102)	$ (16)	$ 34

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Detail) - shares shares in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Equity [Abstract]
Shares of common stock, authorized (in shares)	600
Shares of common stock, outstanding (in shares)	203.7
Stock issued during period, shares, new issues (in shares)	0.9	0.8

Stockholders' Equity - Outstand

Stockholders' Equity - Outstanding and Reserved Shares of Common Stock for Future Issuance (Detail) - shares shares in Thousands	Mar. 31, 2023	Dec. 31, 2022
Stock plans:
Options outstanding (in shares)	1,233	1,237
Total shares of common stock reserved for future issuance (in shares)	21,182
2021 Equity Incentive Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	1,966
Amended and Restated 2012 Employee Stock Purchase Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	8,693
2022 New-Hire Equity Incentive Plan
Stock plans:
Total shares of common stock reserved for future issuance (in shares)	869
Options outstanding
Stock plans:
Options outstanding (in shares)	1,233
RSUs
Stock plans:
RSUs (in shares)	8,421	5,737

Equity Awards - Narrative (Deta

Equity Awards - Narrative (Detail) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) plan $ / shares shares	Mar. 31, 2022 USD ($) $ / shares	Dec. 31, 2022 shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of equity incentive plans | plan	3
Aggregate intrinsic value, exercised	$ 1	$ 22
Fair value of stock options vested	$ 2	$ 3
Weighted-average grant date fair value of options granted (in USD per share) | $ / shares		$ 273.63
Granted (in shares) | shares	0
Total unrecognized compensation cost, adjusted for estimated forfeitures, related to unvested stock options	$ 66
Common stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining weighted-average period	1 year
Restricted stock units with service condition only
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares) | shares	7,800,000
Restricted stock units with service and performance conditions
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares outstanding (in shares) | shares	600,000
Performance-based RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)	100%
Stock-based compensation expense, net of actual and estimated forfeitures	$ 35	$ 29
Performance-based RSUs | Vesting, tranche one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting term	2 years
Performance-based RSUs | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)	0%
Performance-based RSUs | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares eligible to vest (percent)	200%
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Remaining weighted-average period	3 years
Number of shares outstanding (in shares) | shares	8,421,000		5,737,000
Aggregate intrinsic value, vested	$ 362	$ 494
Aggregate intrinsic value, outstanding	3,900
Aggregated intrinsic value, expected to vest	$ 3,400
Granted (in USD per share) | $ / shares	$ 465.57	$ 589.15
Unrecognized compensation expense expected to be recognized	$ 3,200
2012 Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock purchase price percentage	85%
Award offering period	6 months

Equity Awards - Summary of Stoc

Equity Awards - Summary of Stock Option Activity (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Number of Shares
Outstanding, beginning balance (in shares)	1,237
Exercised (in shares)	(4)
Canceled/forfeited (in shares)	0
Outstanding, ending balance (in shares)	1,233
Vested and expected to vest (in shares)	965
Vested and exercisable (in shares)	149
Weighted- Average Exercise Price Per Share
Outstanding, beginning balance (in USD per share)	$ 590.36
Exercised (in USD per share)	71.26
Canceled/forfeited (in USD per share)	84.97
Outstanding, ending balance (in USD per share)	591.98
Vested and expected to vest (in USD per share)	572.11
Vested and exercisable (in USD per share)	$ 171.79
Weighted-average remaining contractual term, outstanding	8 years 1 month 6 days
Weighted-average remaining contractual term, vested and expected to vest	8 years
Weighted-average remaining contractual term, vested and exercisable	5 years 1 month 6 days
Aggregate intrinsic value, exercised	$ 1	$ 22
Aggregate intrinsic value, outstanding	58
Aggregate intrinsic value, vested and expected to vest	56
Aggregate intrinsic value, vested and exercisable	$ 44

Equity Awards - Restricted Stoc

Equity Awards - Restricted Stock Unit Table (Details) - RSUs - $ / shares shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Number of Shares
Outstanding, beginning balance (in shares)	5,737
Granted (in shares)	3,590
Vested (in shares)	(797)
Forfeited (in shares)	(109)
Outstanding, ending balance (in shares)	8,421
Expected to vest (in shares)	7,210
Weighted-Average Grant-Date Fair Value Per Share
Outstanding, beginning balance (in USD per share)	$ 505.79
Granted (in USD per share)	465.57	$ 589.15
Vested (in USD per share)	448.61
Forfeited (in USD per share)	504.48
Outstanding, ending balance (in USD per share)	$ 494.49

Net Income Per Share - Schedule

Net Income Per Share - Schedule of Basic and Diluted Net Income Per Share Attributable to Common Stockholders (Detail) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Numerator:
Net income	$ 150	$ 75
Denominator:
Weighted-average shares outstanding - basic (in shares)	203,385	200,088
Weighted-average shares outstanding - diluted (in shares)	204,263	202,800
Net income per share - basic (in USD per share)	$ 0.74	$ 0.38
Net income per share - diluted (in USD per share)	$ 0.73	$ 0.37
Common stock options
Denominator:
Potentially dilutive securities (in shares)	109	180
RSUs
Denominator:
Potentially dilutive securities (in shares)	769	1,892
2022 Warrants | Warrants
Denominator:
Potentially dilutive securities (in shares)	0	640

Net Income Per Share - Schedu_2

Net Income Per Share - Schedule of Potentially Dilutive Securities (Detail) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	7,731	5,636
Common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	1,028	1,022
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	6,509	3,766
ESPP obligations
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	194	159
2022 Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive securities (in shares)	0	689

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		7 Months Ended	36 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Sep. 30, 2023	Dec. 31, 2022
Income Taxes [Line Items]
Income tax provision	$ 38	$ 10
Pre-tax income				$ 338
Domestic Tax Authority
Income Taxes [Line Items]
Permanent differences and other comprehensive losses				720
Cumulative loss from continuing operations before income taxes, domestic				$ 380
Minimum | Forecast
Income Taxes [Line Items]
Adjustment			$ 1,000
Maximum | Forecast
Income Taxes [Line Items]
Adjustment			$ 1,200

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Aug. 31, 2020
Debt Instrument [Line Items]
Operating lease costs	$ 31	$ 27
Operating lease liabilities, payments	19	19
Right-of-use assets obtained in exchange for operating lease liabilities	$ 24	$ 15
Weighted-average lease remaining lease term	9 years
Weighted-average discount rate	4%
Undiscounted cash flows	$ 70
Operating lease term	12 years
Purchase agreement	$ 500
Unrecognized tax benefits	33
2030 Notes
Debt Instrument [Line Items]
Principal	$ 1,500		$ 1,500

Commitments and Contingencies_2

Commitments and Contingencies - Maturity of Operating Lease Liabilities (Details) $ in Millions	Mar. 31, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Remainder of 2023	$ 89
2024	100
2025	104
2026	85
2027	75
Thereafter	448
Total operating lease payments	901
Less: imputed interest	(149)
Present value of operating lease liabilities	$ 752

Information about Geographic _3

Information about Geographic Areas and Products - Geographic Disclosures (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Revenues by geography
Total revenues	$ 2,096	$ 1,722
Property and equipment by geography
Property and equipment, net	$ 1,117		$ 1,053
Percentage of U.S. revenues in North America	94%	94%
Percentage of U.S. net property and equipment in North America	83%		85%
North America
Revenues by geography
Total revenues	$ 1,344	$ 1,116
Property and equipment by geography
Property and equipment, net	720		$ 664
EMEA
Revenues by geography
Total revenues	532	434
Property and equipment by geography
Property and equipment, net	220		221
Asia Pacific and other
Revenues by geography
Total revenues	220	$ 172
Property and equipment by geography
Property and equipment, net	$ 177		$ 168

Information about Geographic _4

Information about Geographic Areas and Products - Subscription Revenues (Detail) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Subscription revenues	$ 2,096	$ 1,722
Digital workflow products
Segment Reporting Information [Line Items]
Subscription revenues	1,790	1,440
ITOM products
Segment Reporting Information [Line Items]
Subscription revenues	234	191
Total subscription revenues
Segment Reporting Information [Line Items]
Subscription revenues	$ 2,024	$ 1,631

Uncategorized Items - now-20230

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]